Bullfrog ai founder and ceo vin singh to present company overview at biofuture 2023

Gaithersburg, md., sept. 25, 2023 (globe newswire) -- bullfrog ai holdings, inc. (nasdaq: bfrg; bfrgw) ("bullfrog ai" or the "company"), a technology-enabled drug development company using artificial intelligence (ai) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced that its founder and ceo vin singh will give a presentation at biofuture 2023 (oct. 4-6, 2023) on the company's recent partnerships, revenue and growth strategy, and portfolio of prodrugs in early-stage clinical development. the presentation will take place on october 5, 2023 at lotte new york palace in new york city.
BFRG Ratings Summary
BFRG Quant Ranking